| scholarly article | Q13442814 |
| P50 | author | Rino Rappuoli | Q2154243 |
| Baudouin Standaert | Q59555061 | ||
| P2860 | cites work | Vaccination greatly reduces disease, disability, death and inequity worldwide | Q24648884 |
| The broader economic impact of vaccination: reviewing and appraising the strength of evidence | Q26786095 | ||
| Cost-effectiveness of infant vaccination with RIX4414 (Rotarix) in the UK. | Q51830023 | ||
| The cost-effectiveness of rotavirus vaccination: Comparative analyses for five European countries and transferability in Europe | Q57515347 | ||
| Population- versus cohort-based modelling approaches. | Q64931893 | ||
| Mothers' attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study | Q79885286 | ||
| The parental appraisal of the morbidity of diarrhea in infants and toddlers (PAMODI) survey | Q80687927 | ||
| Cost effectiveness has its place, but so does common sense | Q85958463 | ||
| Re-evaluating cost effectiveness of universal meningitis vaccination (Bexsero) in England: modelling study | Q34316082 | ||
| Conditions for the near equivalence of cost-effectiveness and cost-benefit analyses. | Q34725841 | ||
| Priority setting of health interventions: the need for multi-criteria decision analysis | Q35017485 | ||
| Exploring the potential impact of rotavirus vaccination on work absenteeism among female administrative personnel of the City of Antwerp through a retrospective database analysis | Q35803191 | ||
| Improvement in hospital Quality of Care (QoC) after the introduction of rotavirus vaccination: An evaluation study in Belgium | Q36255821 | ||
| Methods for Health Economic Evaluation of Vaccines and Immunization Decision Frameworks: A Consensus Framework from a European Vaccine Economics Community | Q36615123 | ||
| National Immunization Therapeutic Advisory Group: it is time for experience sharing and best practice learning | Q36714649 | ||
| The economic value of vaccination: why prevention is wealth | Q36714713 | ||
| Medium- to Long-Term Impact of Rotavirus Vaccination on Hospital Care in Belgium: A 7-Year Follow-Up of the Rotavirus Belgium Impact Study (RotaBIS). | Q36739996 | ||
| Impact of HIV infection on Zambian businesses | Q36888411 | ||
| Methodological Challenges to Economic Evaluations of Vaccines: Is a Common Approach Still Possible? | Q36914109 | ||
| The impact of human papillomavirus information on perceived risk of cervical cancer. | Q37171923 | ||
| The Sustained Rotavirus Vaccination Impact on Nosocomial Infection, Duration of Hospital Stay, and Age: The RotaBIS Study (2005-2012). | Q37444783 | ||
| Budget constraint and vaccine dosing: a mathematical modelling exercise. | Q37522192 | ||
| WHO Guide for standardisation of economic evaluations of immunization programmes | Q37536433 | ||
| Impact of the national rotavirus vaccination programme on acute gastroenteritis in England and associated costs averted | Q37607887 | ||
| Potential mechanisms for HPV vaccine-induced long-term protection | Q37759822 | ||
| Using threshold values for cost per quality-adjusted life-year gained in healthcare decisions | Q37831993 | ||
| Assessing the value of healthcare interventions using multi-criteria decision analysis: a review of the literature | Q38185989 | ||
| Rotavirus vaccination in Europe: drivers and barriers. | Q38206627 | ||
| Modelling the seasonality of rotavirus disease and the impact of vaccination in England and Wales | Q38882821 | ||
| Reassessing the value of vaccines | Q38927785 | ||
| The impact of rotavirus vaccination on discounted net tax revenue in Egypt: a government perspective analysis | Q38951775 | ||
| Is It Time for Vaccination to "Go Viral"? | Q39353826 | ||
| Comparing cost-effectiveness results for a vaccine across different countries worldwide: what can we learn? | Q41694316 | ||
| Fiscal consequences of changes in morbidity and mortality attributed to rotavirus immunisation | Q43698881 | ||
| Estimating utility scores in young children with acute rotavirus gastroenteritis in the UK. | Q43769140 | ||
| Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France | Q44931333 | ||
| Evaluating societal preferences for human papillomavirus vaccine and cervical smear test screening programme. | Q45917898 | ||
| Selecting a mix of prevention strategies against cervical cancer for maximum efficiency with an optimization program | Q48030944 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P304 | page(s) | 1336044 | |
| P577 | publication date | 2017-08-31 | |
| P1433 | published in | Journal of market access & health policy | Q27727071 |
| P1476 | title | 3. How comprehensive can we be in the economic assessment of vaccines? | |
| P478 | volume | 5 |
Search more.